The Scientist

» blogging

Most Recent

image: Setting the Record Straight

Setting the Record Straight

By | October 1, 2014

Scientists are taking to social media to challenge weak research, share replication attempts in real time, and counteract hype. Will this online discourse enrich the scientific process?

3 Comments

image: Welcome Back, Pharmalot

Welcome Back, Pharmalot

By | June 4, 2014

The Wall Street Journal revives the popular blog covering pharmaceutical and biotech industry news.

0 Comments

image: Blogger Reports STAP Success

Blogger Reports STAP Success

By | April 1, 2014

A stem-cell researcher claims to have reproduced stimulus-triggered acquisition of pluripotency by following a revised protocol posted online last week.

2 Comments

image: Goodbye, Pharmalot

Goodbye, Pharmalot

By | January 2, 2014

The popular blog covering pharmaceutical and biotech industry news has been shuttered.  

2 Comments

image: Fraud Watchdog Blogger Revealed

Fraud Watchdog Blogger Revealed

By | January 6, 2013

The author of a whistleblower blog has revealed his identity after the site was suspended due to legal threats from accused scientists.

3 Comments

image: Arsenic-based Life Challenged Again

Arsenic-based Life Challenged Again

By | January 24, 2012

An attempt to regrow the infamous GFAJ-1 bacteria, reported to incorporate arsenic into its DNA backbone, has failed.

9 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham